Maintenance immunosuppressive therapy in adult renal transplantation: A single center analysis

被引:6
作者
Saeemann, Marcus D. [1 ]
Sunder-Plassmann, Gere [1 ]
机构
[1] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, A-1090 Vienna, Austria
关键词
Kidney; Transplantation; Immunosuppression;
D O I
10.1016/j.trim.2008.08.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study we have analyzed the maintenance immunosuppression of renal transplant patients followed at the Medical University of Vienna. Since more than thousand renal transplant patients are registered and treated at this center, our data reveal the pattern as well as the current and past practices of the prescription of immunosuppressive drugs in a large outpatient setting. The majority of patients displayed a transplant vintage of more than 5 years and used calcineurin inhibitors (CNIs), and/or steroids and/or antimetabolites reflecting the general prescription profile of immunosuppressive drugs in renal transplant recipients. However, the selection of immunosuppressive combinations as well as the dynamics of the immunosuppressive regimen in the life of the stable allograft recipient - minimization, conversion and/or withdrawal of one or more of each of the drugs - are not founded on strong data derived from adequately powered clinical trials but rather follows a mixture of various smaller and medium-sized clinical studies and the individual center attitude based on mostly center-specific uncontrolled clinical observations. Hence, the maintenance immunosuppression of transplant patients is the result of a strong empirical attitude and only adequately powered prospective trials may inform us which immunosuppressive regimen and overall strategy will be ideal for the individual renal transplant recipient. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 72 条
[1]  
Ahsan N, 1999, TRANSPLANTATION, V68, P1865
[2]  
Andany MA, 2001, J NEPHROL, V14, pS81
[3]   Minimization of immunosuppression in kidney transplantation [J].
Augustine, Joshua J. ;
Hricik, Donald E. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2007, 16 (06) :535-541
[4]   Steroid sparing in kidney transplantation: Changing paradigms, improving outcomes, and remaining questions [J].
Augustine, Joshua J. ;
Hricik, Donald E. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05) :1080-1089
[5]   Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod [J].
Babel, N. ;
Eibl, N. ;
Ulrich, C. ;
Bold, G. ;
Sefrin, A. ;
Hammer, M. H. ;
Rosenberger, C. ;
Reinke, P. .
TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (01) :59-62
[6]   CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS [J].
BATIUK, TD ;
PAZDERKA, F ;
HALLORAN, PF .
TRANSPLANTATION, 1995, 59 (10) :1400-1404
[7]   CYCLOSPORINE INHIBITION OF CALCINEURIN ACTIVITY IN HUMAN-LEUKOCYTES IN-VIVO IS RAPIDLY REVERSIBLE [J].
BATIUK, TD ;
PAZDERKA, F ;
ENNS, J ;
DECASTRO, L ;
HALLORAN, PF .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1254-1260
[8]  
Bîrsan T, 2004, TRANSPLANTATION, V78, P1787
[9]   Reccurence of Kaposi's sarcoma after increased exposure to sirolimus [J].
Boratynska, Maria ;
Zmonarski, Slawomir C. ;
Klinger, Marian .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (13-14) :2018-2022
[10]   The role of tacrolimus in renal transplantation [J].
Bowman, Lyndsey J. ;
Brennan, Daniel C. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) :635-643